Clinical Trial Update: Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of meloxicam nanocrystal injection for moderate to severe pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Meloxicam nanocrystal injection (meloxicam)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Pain | Phase 3 | Status: COMPLETED